InvestorsHub Logo
Followers 16
Posts 4127
Boards Moderated 2
Alias Born 07/22/2004

Re: longmike2 post# 1833

Thursday, 05/31/2007 2:07:33 AM

Thursday, May 31, 2007 2:07:33 AM

Post# of 6451
"News shouldn't be that bad" ?

I'd think the news is going to be pretty black and white here, I don't think there's "not that bad" option.

If one trial has good results and the other doesn't, that's bad.

If both trials have "pretty good" results, but aren't clear cut successes in terms of FDA submission and approval, that's bad for current share price.

A situation like that might provide a great opportunity down the road to gamble on whether the FDA will approve Prehistin on borderline results, but it would be bad for current share price.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.